Inactive Instrument

Avivagen Inc. Stock Toronto S.E.

VIV.H

CA05382F2026

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that enhances feed intake and supports immune function, thereby supporting general health and performance. The Companyâ€™s operations as one segment, products based on OxC-beta Technology. Its OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia.

Employees

Sector

Fishing & Farming

More about the company

-40%: Exceptional extension

SEIZE THE OFFER!

Market Cap	591K 515K 485K 442K 829K 56.61M 830K 5.81M 2.24M 28.84M 2.22M 2.17M 93.06M	P/E 2021	-3.05x	P/E 2022	-1.52x
Enterprise Value	6.39M 5.57M 5.24M 4.78M 8.95M 612M 8.97M 62.81M 24.21M 312M 23.99M 23.46M 1.01B	EV / Sales 2021	20.5x	EV / Sales 2022	17.7x
Free-Float	98.89%	Yield 2021 *	-	Yield 2022	-

24-04-24	Avivagen Makes Voluntary Assignment into Bankruptcy Under the BIA	NE
21-04-06	Avivagen Discusses Significant Purchase Orders for OxC-beta(TM) Livestock with The Stock Day Podcast	NE
20-07-23	Avivagen: The OxC-beta(TM) Technology Is A True Game Changer	NE
19-10-02	Avivagen Inc. CEO, Kym Anthony, Joins The Stock Day Podcast to Discuss Their Expansion Strategy	NE
18-05-01	Avivagen Announces its Attendance at the Bloom Burton & Co. Healthcare Investor Conference	GL

Manager	Title	Age	Since
G. Anthony CEO	Chief Executive Officer	70	2017-02-08
Ira Levy DFI	Director of Finance/CFO	-	-
Drew Basek IRC	Investor Relations Contact	-	2017-02-28

Director	Title	Age	Since
David Hankinson CHM	Chairman	-	2005-08-03
G. Anthony CHM	Chairman	70	2014-07-24
Paul Mesburis BRD	Director/Board Member	56	2016-04-04

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AVIVAGEN INC.	-.--%	-.--%	-	-	77
GUANGDONG HAID GROUP CO., LIMITED	+1.05%	-0.45%	-33.09%	-9.42%	10.29B
NEW HOPE LIUHE CO.,LTD.	+1.68%	-1.36%	-26.69%	-35.23%	4.78B
PT CHAROEN POKPHAND INDONESIA TBK	-1.27%	-0.64%	-38.72%	-37.17%	2.91B
AKTIESELSKABET SCHOUW & CO.	-0.50%	-0.13%	+31.62%	+63.92%	2.74B
BEIJING DABEINONG TECHNOLOGY GROUP CO.,LTD.	+2.19%	+0.62%	-22.57%	-51.34%	2.04B
FUJIAN AONONG BIOLOGICAL TECHNOLOGY GROUP INCORPORATION LIMITED	+2.42%	-1.00%	-42.64%	-63.37%	1.18B
AVANTI FEEDS LIMITED	+0.75%	+0.33%	+8.96%	+77.92%	1.1B
FUJIAN TIANMA SCIENCE AND TECHNOLOGY GROUP CO., LTD	-2.47%	+3.27%	-16.78%	-11.87%	979M
WELLHOPE FOODS CO., LTD.	+3.16%	-2.10%	-21.16%	-25.57%	812M
Average	+0.72%	+0.77%	-17.89%	-10.24%	2.98B
Weighted average by Cap.	+0.83%	+0.24%	-22.88%	-12.08%

Avivagen Inc. Stock Toronto S.E.

Stocks

VIV.H

CA05382F2026

Fishing & Farming

Valuation: Avivagen Inc.

Press Releases: Avivagen Inc.

Managers and Directors: Avivagen Inc.

Animal Feed

Financials

Company Profile

	2021	2022
Net sales	1.3M 1.13M 1.06M 969K 1.82M 124M 1.82M 12.75M 4.91M 63.25M 4.87M 4.76M 204M	939K 819K 771K 702K 1.32M 89.98M 1.32M 9.24M 3.56M 45.83M 3.53M 3.45M 148M
Net income	-6.39M -5.58M -5.25M -4.78M -8.97M -613M -8.98M -62.88M -24.24M -312M -24.02M -23.49M -1.01B	-6.07M -5.29M -4.98M -4.54M -8.51M -581M -8.52M -59.66M -22.99M -296M -22.79M -22.28M -955M
Net Debt	5.4M 4.71M 4.43M 4.04M 7.57M 517M 7.58M 53.09M 20.46M 263M 20.28M 19.83M 850M	5.8M 5.05M 4.76M 4.33M 8.13M 555M 8.14M 56.99M 21.97M 283M 21.77M 21.29M 913M